Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides

Land plants produce a vast arsenal of specialized metabolites and many of them display interesting bioactivities in humans. Recently, flavonol quercetin gained great attention in the light of the COVID-19 pandemic because, in addition to the anti-inflammatory, antiviral and anti-cancer activity alre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stefano Negri, Sofia Gambini, Stefania Ceoldo, Linda Avesani, Mauro Commisso, Flavia Guzzo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/7ee8610687164462ab1390fab1518eda
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ee8610687164462ab1390fab1518eda
record_format dspace
spelling oai:doaj.org-article:7ee8610687164462ab1390fab1518eda2021-11-25T18:47:06ZUndifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides10.3390/plants101124992223-7747https://doaj.org/article/7ee8610687164462ab1390fab1518eda2021-11-01T00:00:00Zhttps://www.mdpi.com/2223-7747/10/11/2499https://doaj.org/toc/2223-7747Land plants produce a vast arsenal of specialized metabolites and many of them display interesting bioactivities in humans. Recently, flavonol quercetin gained great attention in the light of the COVID-19 pandemic because, in addition to the anti-inflammatory, antiviral and anti-cancer activity already described, it emerged as possible inhibitor of 3CLpro, the major protease of SARS-CoV-2 virus. Plant cell and tissue culture (PCTC) is an attractive platform for the biotechnological production of plant metabolites. This technology allows a large amount of water and agricultural land to be saved and, being free of contaminants in the process, it is suitable for scaling up the production in bioreactors. In a project aimed to generate and screen in vitro plant cells for the production of valuable specialized metabolites for commercial production, we generated various cell lines from <i>Actinidia deliciosa</i> (kiwi fruit tree) and <i>Actinidia chinensis</i> (gold kiwi fruit tree), that were able to produce relevant amounts of quercetin derivatives, mainly quercetin glycosides. Three cell lines from <i>A. deliciosa</i> were characterized by targeted and untargeted metabolomics. In standard growing conditions, they produce and accumulate up to 13.26 mg/100 g fresh weight (419.76 mg/100 g dry weight) of quercetin derivatives. To address future industrial applications, these cell lines should be entered into an acceleration program to further increase the amount of these metabolites by optimizing the culture conditions and elicitation.Stefano NegriSofia GambiniStefania CeoldoLinda AvesaniMauro CommissoFlavia GuzzoMDPI AGarticlequercetinflavonoidsplant cell and tissue culture<i>Actinida deliciosa</i><i>Actinidia chinensis</i>BotanyQK1-989ENPlants, Vol 10, Iss 2499, p 2499 (2021)
institution DOAJ
collection DOAJ
language EN
topic quercetin
flavonoids
plant cell and tissue culture
<i>Actinida deliciosa</i>
<i>Actinidia chinensis</i>
Botany
QK1-989
spellingShingle quercetin
flavonoids
plant cell and tissue culture
<i>Actinida deliciosa</i>
<i>Actinidia chinensis</i>
Botany
QK1-989
Stefano Negri
Sofia Gambini
Stefania Ceoldo
Linda Avesani
Mauro Commisso
Flavia Guzzo
Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides
description Land plants produce a vast arsenal of specialized metabolites and many of them display interesting bioactivities in humans. Recently, flavonol quercetin gained great attention in the light of the COVID-19 pandemic because, in addition to the anti-inflammatory, antiviral and anti-cancer activity already described, it emerged as possible inhibitor of 3CLpro, the major protease of SARS-CoV-2 virus. Plant cell and tissue culture (PCTC) is an attractive platform for the biotechnological production of plant metabolites. This technology allows a large amount of water and agricultural land to be saved and, being free of contaminants in the process, it is suitable for scaling up the production in bioreactors. In a project aimed to generate and screen in vitro plant cells for the production of valuable specialized metabolites for commercial production, we generated various cell lines from <i>Actinidia deliciosa</i> (kiwi fruit tree) and <i>Actinidia chinensis</i> (gold kiwi fruit tree), that were able to produce relevant amounts of quercetin derivatives, mainly quercetin glycosides. Three cell lines from <i>A. deliciosa</i> were characterized by targeted and untargeted metabolomics. In standard growing conditions, they produce and accumulate up to 13.26 mg/100 g fresh weight (419.76 mg/100 g dry weight) of quercetin derivatives. To address future industrial applications, these cell lines should be entered into an acceleration program to further increase the amount of these metabolites by optimizing the culture conditions and elicitation.
format article
author Stefano Negri
Sofia Gambini
Stefania Ceoldo
Linda Avesani
Mauro Commisso
Flavia Guzzo
author_facet Stefano Negri
Sofia Gambini
Stefania Ceoldo
Linda Avesani
Mauro Commisso
Flavia Guzzo
author_sort Stefano Negri
title Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides
title_short Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides
title_full Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides
title_fullStr Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides
title_full_unstemmed Undifferentiated In Vitro Cultured <i>Actinidia deliciosa</i> as Cell Factory for the Production of Quercetin Glycosides
title_sort undifferentiated in vitro cultured <i>actinidia deliciosa</i> as cell factory for the production of quercetin glycosides
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/7ee8610687164462ab1390fab1518eda
work_keys_str_mv AT stefanonegri undifferentiatedinvitroculturediactinidiadeliciosaiascellfactoryfortheproductionofquercetinglycosides
AT sofiagambini undifferentiatedinvitroculturediactinidiadeliciosaiascellfactoryfortheproductionofquercetinglycosides
AT stefaniaceoldo undifferentiatedinvitroculturediactinidiadeliciosaiascellfactoryfortheproductionofquercetinglycosides
AT lindaavesani undifferentiatedinvitroculturediactinidiadeliciosaiascellfactoryfortheproductionofquercetinglycosides
AT maurocommisso undifferentiatedinvitroculturediactinidiadeliciosaiascellfactoryfortheproductionofquercetinglycosides
AT flaviaguzzo undifferentiatedinvitroculturediactinidiadeliciosaiascellfactoryfortheproductionofquercetinglycosides
_version_ 1718410721184710656